lansoprazole has been researched along with Calcinosis in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Calcinosis: Pathologic deposition of calcium salts in tissues.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Arita, Y | 1 |
Nakayama, M | 1 |
Matsukuma, Y | 1 |
Yoshitomi, R | 1 |
Seki, M | 1 |
Fukui, A | 1 |
Tsuda, S | 1 |
Sonoda, Y | 1 |
Imazu, R | 1 |
Arakawa, K | 1 |
Tominaga, M | 1 |
Nakano, T | 1 |
Tsuruya, K | 1 |
Kitazono, T | 1 |
1 other study available for lansoprazole and Calcinosis
Article | Year |
---|---|
Association of aortic valve calcification with carotid artery lesions and peripheral artery disease in patients with chronic kidney disease: a cross-sectional study.
Topics: Adult; Aged; Aged, 80 and over; Ankle Brachial Index; Aortic Valve; Aortic Valve Stenosis; Calcinosi | 2020 |